Infectious Disease Modelling of HIV Prevention Interventions: A Systematic Review and Narrative Synthesis of Compartmental Models.
Journal
PharmacoEconomics
ISSN: 1179-2027
Titre abrégé: Pharmacoeconomics
Pays: New Zealand
ID NLM: 9212404
Informations de publication
Date de publication:
06 2023
06 2023
Historique:
accepted:
26
02
2023
medline:
8
5
2023
pubmed:
30
3
2023
entrez:
29
3
2023
Statut:
ppublish
Résumé
The HIV epidemic remains a major public health problem. Critical to transmission control are HIV prevention strategies with new interventions continuing to be developed. Mathematical models are important for understanding the potential impact of these interventions and supporting policy decisions. This systematic review aims to answer the following question: when a new HIV prevention intervention is being considered or designed, what information regarding it is necessary to include in a compartmental model to provide useful insights to policy makers? The primary objective of this review is therefore to assess suitability of current compartmental HIV prevention models for informing policy development. Articles published in EMBASE, Medline, Econlit, and Global Health were screened. Included studies were identified using permutations of (i) HIV, (ii) pre-exposure prophylaxis (PrEP), circumcision (both voluntary male circumcision [VMMC] and early-infant male circumcision [EIMC]), and vaccination, and (iii) modelling. Data extraction focused on study design, model structure, and intervention incorporation into models. Article quality was assessed using the TRACE (TRAnsparent and Comprehensive Ecological modelling documentation) criteria for mathematical models. Of 837 articles screened, 48 articles were included in the review, with 32 unique mathematical models identified. The substantial majority of studies included PrEP (83%), whilst fewer modelled circumcision (54%), and only a few focussed on vaccination (10%). Data evaluation, implementation verification, and model output corroboration were identified as areas of poorer model quality. Parameters commonly included in the mathematical models were intervention uptake and effectiveness, with additional intervention-specific common parameters identified. We identified key modelling gaps; critically, models insufficiently incorporate multiple interventions acting simultaneously. Additionally, population subgroups were generally poorly represented-with future models requiring improved incorporation of ethnicity and sexual risk group stratification-and many models contained inappropriate data in parameterisation which will affect output accuracy. This review identified gaps in compartmental models to date and suggests areas of improvement for models focusing on new prevention interventions. Resolution of such gaps within future models will ensure greater robustness and transparency, and enable more accurate assessment of the impact that new interventions may have, thereby providing more meaningful guidance to policy makers.
Sections du résumé
BACKGROUND
The HIV epidemic remains a major public health problem. Critical to transmission control are HIV prevention strategies with new interventions continuing to be developed. Mathematical models are important for understanding the potential impact of these interventions and supporting policy decisions. This systematic review aims to answer the following question: when a new HIV prevention intervention is being considered or designed, what information regarding it is necessary to include in a compartmental model to provide useful insights to policy makers? The primary objective of this review is therefore to assess suitability of current compartmental HIV prevention models for informing policy development.
METHODS
Articles published in EMBASE, Medline, Econlit, and Global Health were screened. Included studies were identified using permutations of (i) HIV, (ii) pre-exposure prophylaxis (PrEP), circumcision (both voluntary male circumcision [VMMC] and early-infant male circumcision [EIMC]), and vaccination, and (iii) modelling. Data extraction focused on study design, model structure, and intervention incorporation into models. Article quality was assessed using the TRACE (TRAnsparent and Comprehensive Ecological modelling documentation) criteria for mathematical models.
RESULTS
Of 837 articles screened, 48 articles were included in the review, with 32 unique mathematical models identified. The substantial majority of studies included PrEP (83%), whilst fewer modelled circumcision (54%), and only a few focussed on vaccination (10%). Data evaluation, implementation verification, and model output corroboration were identified as areas of poorer model quality. Parameters commonly included in the mathematical models were intervention uptake and effectiveness, with additional intervention-specific common parameters identified. We identified key modelling gaps; critically, models insufficiently incorporate multiple interventions acting simultaneously. Additionally, population subgroups were generally poorly represented-with future models requiring improved incorporation of ethnicity and sexual risk group stratification-and many models contained inappropriate data in parameterisation which will affect output accuracy.
CONCLUSIONS
This review identified gaps in compartmental models to date and suggests areas of improvement for models focusing on new prevention interventions. Resolution of such gaps within future models will ensure greater robustness and transparency, and enable more accurate assessment of the impact that new interventions may have, thereby providing more meaningful guidance to policy makers.
Identifiants
pubmed: 36988896
doi: 10.1007/s40273-023-01260-z
pii: 10.1007/s40273-023-01260-z
pmc: PMC10163138
doi:
Types de publication
Systematic Review
Research Support, Non-U.S. Gov't
Langues
eng
Pagination
693-707Subventions
Organisme : PEPFAR
Pays : United States
Informations de copyright
© 2023. The Author(s).
Références
HIV.gov. The Global HIV/AIDS Epidemic [Internet]. 2021 [cited 2022 Feb 9]. Available from: https://www.hiv.gov/hiv-basics/overview/data-and-trends/global-statistics .
World health organisation. HIV/AIDS [Internet]. [cited 2022 Dec 2]. Available from: https://www.who.int/health-topics/hiv-aids#tab=tab_1
UNAIDS. 90-90-90: An ambitious treatment target to help end the AIDS epidemic [Internet]. 2014. Available from: https://www.unaids.org/sites/default/files/media_asset/90-90-90_en.pdf
UNAIDS. 2025 AIDS targets: Target-Setting, Impact and Resource Needs for the Global AIDS Response. Technical consultation on primary prevention [Internet]. 2019 [cited 2022 Feb 9]. Available from: https://www.unaids.org/sites/default/files/2025targets-PreventionMeeting_March2019.pdf
Mugo NR, Ngure K, Kiragu M, Irungu E, Kilonzo N. The preexposure prophylaxis revolution; from clinical trials to programmatic implementation. Curr Opin HIV AIDS. 2016;11:80–6.
pubmed: 26575147
pmcid: 4900687
doi: 10.1097/COH.0000000000000224
World health organisation. HIV/AIDs: Key facts [Internet]. 2021 [cited 2022 Feb 9]. Available from: https://www.who.int/news-room/fact-sheets/detail/hiv-aids .
World health Organization. WHO recommends the dapivirine vaginal ring as a new choice for HIV prevention for women at substantial risk of HIV infection [Internet]. 2021 [cited 2021 Jul 12]. Available from: https://www.who.int/news/item/26-01-2021-who-recommends-the-dapivirine-vaginal-ring-as-a-new-choice-for-hiv-prevention-for-women-at-substantial-risk-of-hiv-infection
Viiv healthcare. FDA grants Priority Review to ViiV Healthcare’s New Drug Application for cabotegravir long-acting for prevention of HIV [Internet]. 2021 [cited 2021 Oct 7]. Available from: https://viivhealthcare.com/en-gb/media/press-releases/2021/september/viiv-healthcare-announces-fda-priority-review/
Kim J, Vasan S, Kim JH, Ake JA. Current approaches to HIV vaccine development: a narrative review. J Int AIDS Soc. 2021;24(7):25793.
Leggat DJ, Cohen KW, Willis JR, Fulp WJ, deCamp AC, Kalyuzhniy O, et al. Vaccination induces HIV broadly neutralizing antibody precursors in humans. Science. 2022;378:6502.
doi: 10.1126/science.add6502
Burton DR. Amping up HIV antibodies. Science (80- ) [Internet]. American Association for the Advancement of Science; 2021;372:1397–8. Available from: https://doi.org/10.1126/science.abf5376
Antibodies for HIV prevention [Internet]. Available from: https://www.iavi.org/phocadownload/iavi_fact_sheet_antibodies_for_hiv_prevention.pdf
Miner MD, Corey L, Montefiori D. Broadly neutralizing monoclonal antibodies for HIV prevention. J Int AIDS Soc. 2021;24(7): e25829.
pubmed: 34806308
pmcid: 8606861
Brown JL, Sales JM, DiClemente RJ. Combination HIV prevention interventions: the potential of integrated behavioral and biomedical approaches. Curr HIV/AIDS Rep. 2014;11:363–75.
pubmed: 25216985
pmcid: 4358895
doi: 10.1007/s11904-014-0228-6
Johnson LF, White PJ. A review of mathematical models of HIV/AIDS interventions and their implications for policy. Sex Transm Infect. 2011;87:629–34.
pubmed: 21685191
doi: 10.1136/sti.2010.045500
Garnett GP, Cousens S, Hallett TB, Steketee R, Walker N. Mathematical models in the evaluation of health programmes. Lancet (London, England). 2011;378:515–25.
pubmed: 21481448
doi: 10.1016/S0140-6736(10)61505-X
Liang P, Zu J, Zhuang G. A literature review of mathematical models of hepatitis B virus transmission applied to immunization strategies from 1994 to 2015. J Epidemiol. 2018;28:221–9.
pubmed: 29276213
pmcid: 5911672
doi: 10.2188/jea.JE20160203
Ma Z, Li J. Dynamical Modeling and Analysis of Epidemics [Internet]. World Scientific Publishing Co. Pte. Ltd; 2009. Available from: https://agus34drajat.files.wordpress.com/2010/10/dynamical-modeling-and-analysis-of-epidemics.pdf
Brisson M, Edmunds WJ. Economic evaluation of vaccination programs: the impact of herd immunity. Med Decis Making. 2003;23:76–82.
pubmed: 12583457
doi: 10.1177/0272989X02239651
Pitman R, Fisman D, Zaric GS, Postma M, Kretzschmar M, Edmunds J, et al. Dynamic transmission modeling: a report of the ISPOR-SMDM modeling good research practices task force—5. Value Health. 2012;15:828–34.
pubmed: 22999132
pmcid: 7110742
doi: 10.1016/j.jval.2012.06.011
Department of Health South Africa, South African National AIDS Council. South African HIV and TB Investment Case - Summary Report Phase 1 [Internet]. Available from: http://www.heroza.org/wp-content/uploads/2016/03/SA-HIV_TB-Investment-Case-Full-Report-Low-Res.pdf
The Global Fund. Step up the fight: Investment case [Internet]. 2019. Available from: https://www.theglobalfund.org/media/8279/publication_sixthreplenishmentinvestmentcase_report_en.pdf
Nepomuceno E, Resende D, Lacerda M. A Survey of the individual-based model applied in biomedical and epidemiology. 2019.
Donkin E, Dennis P, Ustalakov A, Warren J, Clare A. Replicating complex agent based models, a formidable task. Environ Model Softw [Internet]. 2017;92:142–51. Available from: https://www.sciencedirect.com/science/article/pii/S1364815216310088
Case KK, Gomez GB, Hallett TB. The impact, cost and cost-effectiveness of oral pre-exposure prophylaxis in sub-Saharan Africa: a scoping review of modelling contributions and way forward. J Int AIDS Soc. 2019;22: e25390.
pubmed: 31538407
pmcid: 6753289
doi: 10.1002/jia2.25390
Bernard CL, Brandeau ML. Structural sensitivity in HIV modeling: a case study of vaccination. Infect Dis Model. 2017;2:399–411.
pubmed: 29532039
pmcid: 5844493
Baggaley RF, Fraser C. Modelling sexual transmission of HIV: testing the assumptions, validating the predictions. Curr Opin HIV AIDS. 2010;5:269–76.
pubmed: 20543600
pmcid: 2923018
doi: 10.1097/COH.0b013e32833a51b2
Grimm V, Augusiak J, Focks A, Frank B, Gabsi F, Johnston ASA, et al. Towards better modelling and decision support: Documenting model development, testing, and analysis using TRACE. Ecol Modell. 2014;280:129–39.
doi: 10.1016/j.ecolmodel.2014.01.018
Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339: b2535.
pubmed: 19622551
pmcid: 2714657
doi: 10.1136/bmj.b2535
Shaw GM, Hunter E. HIV transmission. Cold Spring Harb Perspect Med. 2012;2.
Public Health Agency of Canada. HIV TRANSMISSION RISK: A SUMMARY OF THE EVIDENCE [Internet]. 2010. Available from: https://www.catie.ca/sites/default/files/HIV-TRANSMISSION-RISK-EN.pdf
Glaubius RL, Hood G, Penrose KJ, Parikh UM, Mellors JW, Bendavid E, et al. Cost-effectiveness of injectable preexposure prophylaxis for HIV prevention in South Africa. Clin Infect Dis. 2016;63:539–47.
pubmed: 27193745
pmcid: 4967601
doi: 10.1093/cid/ciw321
Glaubius RL, Parikh UM, Hood G, Penrose KJ, Bendavid E, Mellors JW, et al. Deciphering the Effects of Injectable Pre-exposure Prophylaxis for Combination Human Immunodeficiency Virus Prevention. Open forum Infect Dis [Internet]. Oxford University Press; 2016;3:ofw125–ofw125. Available from: https://pubmed.ncbi.nlm.nih.gov/27703992
van Vliet MM, Hendrickson C, Nichols BE, Boucher CA, Peters RP, van de Vijver DA. Epidemiological impact and cost-effectiveness of providing long-acting pre-exposure prophylaxis to injectable contraceptive users for HIV prevention in South Africa: a modelling study. J Int AIDS Soc. 2019;22: e25427.
pubmed: 31855323
pmcid: 6922023
doi: 10.1002/jia2.25427
Glaubius R, Ding Y, Penrose KJ, Hood G, Engquist E, Mellors JW, et al. Dapivirine vaginal ring for HIV prevention: modelling health outcomes, drug resistance and cost-effectiveness. J Int AIDS Soc. 2019;22: e25282.
pubmed: 31074936
pmcid: 6510112
doi: 10.1002/jia2.25282
Smith JA, Anderson S-J, Harris KL, McGillen JB, Lee E, Garnett GP, et al. Maximising HIV prevention by balancing the opportunities of today with the promises of tomorrow: a modelling study. Lancet HIV. 2016;3:e289–96.
pubmed: 27365203
pmcid: 4935669
doi: 10.1016/S2352-3018(16)30036-4
Dimitrov D, Kublin JG, Ramsey S, Corey L. Are clade specific HIV vaccines a necessity? An analysis based on mathematical models. EBioMedicine. 2015;2:2062–9.
pubmed: 26844286
pmcid: 4703729
doi: 10.1016/j.ebiom.2015.11.009
Punyacharoensin N, Edmunds WJ, De Angelis D, Delpech V, Hart G, Elford J, et al. Effect of pre-exposure prophylaxis and combination HIV prevention for men who have sex with men in the UK: a mathematical modelling study. lancet HIV. Netherlands; 2016;3:e94–104.
Alsallaq RA, Buttolph J, Cleland CM, Hallett T, Inwani I, Agot K, et al. The potential impact and cost of focusing HIV prevention on young women and men: A modeling analysis in western Kenya. PLoS ONE. 2017;12: e0175447.
pubmed: 28403211
pmcid: 5389814
doi: 10.1371/journal.pone.0175447
Cepeda J, Borquez A, Farrell M, Degenhardt L, McKetin R, Tran LT, et al. Integrating HIV pre-exposure prophylaxis and harm reduction among men who have sex with men and transgender women to address intersecting harms associated with stimulant use: a modelling study. J Int AIDS Soc [Internet]. Switzerland: John Wiley and Sons Inc. (E-mail: cs-journals@wiley.com); 2020;23 Suppl 1:e25495. Available from: http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=med18&NEWS=N&AN=32562365
Kelly SL, Martin-Hughes R, Stuart RM, Yap XF, Kedziora DJ, Grantham KL, et al. The global Optima HIV allocative efficiency model: targeting resources in efforts to end AIDS. Lancet HIV. 2018;5:e190–8.
pubmed: 29540265
doi: 10.1016/S2352-3018(18)30024-9
Pharaon J, Bauch CT. The impact of pre-exposure prophylaxis for human immunodeficiency virus on gonorrhea prevalence. Bull Math Biol. 2020;82:85.
pubmed: 32613297
doi: 10.1007/s11538-020-00762-7
Medlock J, Pandey A, Parpia AS, Tang A, Skrip LA, Galvani AP. Effectiveness of UNAIDS targets and HIV vaccination across 127 countries. Proc Natl Acad Sci U S A. 2017;114:4017–22.
pubmed: 28320938
pmcid: 5393239
doi: 10.1073/pnas.1620788114
Afassinou K, Chirove F, Govinder KS. Pre-exposure prophylaxis and antiretroviral treatment interventions with drug resistance. Math Biosci. 2017;285:92–101.
pubmed: 28095307
doi: 10.1016/j.mbs.2017.01.005
Akudibillah G, Pandey A, Medlock J. Maximizing the benefits of ART and PrEP in resource-limited settings. Epidemiol Infect. 2017;145:942–56.
pubmed: 28031062
doi: 10.1017/S0950268816002958
de Montigny S, Adamson BJS, Mâsse BR, Garrison LPJ, Kublin JG, Gilbert PB, et al. Projected effectiveness and added value of HIV vaccination campaigns in South Africa: A modeling study. Sci Rep. 2018;8:6066.
pubmed: 29666455
pmcid: 5904131
doi: 10.1038/s41598-018-24268-4
Bórquez A, Guanira JV, Revill P, Caballero P, Silva-Santisteban A, Kelly S, et al. The impact and cost-effectiveness of combined HIV prevention scenarios among transgender women sex-workers in Lima, Peru: a mathematical modelling study. Lancet Public Heal. 2019;4:e127–36.
doi: 10.1016/S2468-2667(18)30236-6
Bernard CL, Owens DK, Goldhaber-Fiebert JD, Brandeau ML. Estimation of the cost-effectiveness of HIV prevention portfolios for people who inject drugs in the United States: a model-based analysis. PLoS Med. 2017;14: e1002312.
pubmed: 28542184
pmcid: 5443477
doi: 10.1371/journal.pmed.1002312
Bernard CL, Brandeau ML, Humphreys K, Bendavid E, Holodniy M, Weyant C, et al. Cost-effectiveness of HIV preexposure prophylaxis for people who inject drugs in the United States. Ann Intern Med. 2016;165:10–9.
pubmed: 27110953
doi: 10.7326/M15-2634
Anderson S-J, Garnett GP, Enstone J, Hallett TB, Anderson SJG, Enstone J, Hallett TB. The importance of local epidemic conditions in monitoring progress towards HIV epidemic control in Kenya: a modelling study. J Int AIDS Soc. 2018;21:e25203.
pubmed: 30485720
pmcid: 6260921
doi: 10.1002/jia2.25203
Cremin I, McKinnon L, Kimani J, Cherutich P, Gakii G, Muriuki F, et al. PrEP for key populations in combination HIV prevention in Nairobi: a mathematical modelling study. Lancet HIV. 2017;4:e214–22.
pubmed: 28233660
doi: 10.1016/S2352-3018(17)30021-8
McGillen JB, Stover J, Klein DJ, Xaba S, Ncube G, Mhangara M, et al. The emerging health impact of voluntary medical male circumcision in Zimbabwe: An evaluation using three epidemiological models. PLoS ONE. 2018;13: e0199453.
pubmed: 30020940
pmcid: 6051576
doi: 10.1371/journal.pone.0199453
Mitchell KM, Prudden HJ, Washington R, Isac S, Rajaram SP, Foss AM, et al. Potential impact of pre-exposure prophylaxis for female sex workers and men who have sex with men in Bangalore, India: a mathematical modelling study. J Int AIDS Soc. 2016;19:20942.
pubmed: 27609782
pmcid: 5016494
doi: 10.7448/IAS.19.1.20942
Stuart RM, Fraser-Hurt N, Kerr CC, Mabusela E, Madi V, Mkhwanazi F, et al. The City of Johannesburg can end AIDS by 2030: modelling the impact of achieving the Fast-Track targets and what it will take to get there. J Int AIDS Soc. 2018;21.
Mitchell KM, Lépine A, Terris-Prestholt F, Torpey K, Khamofu H, Folayan MO, et al. Modelling the impact and cost-effectiveness of combination prevention amongst HIV serodiscordant couples in Nigeria. AIDS [Internet]. Lippincott Williams & Wilkins; 2015;29:2035–44. Available from: https://pubmed.ncbi.nlm.nih.gov/26355574
Ying R, Sharma M, Heffron R, Celum CL, Baeten JM, Katabira E, et al. Cost-effectiveness of pre-exposure prophylaxis targeted to high-risk serodiscordant couples as a bridge to sustained ART use in Kampala. Uganda J Int AIDS Soc. 2015;18:20013.
pubmed: 26198348
doi: 10.7448/IAS.18.4.20013
Marukutira T, Scott N, Kelly SL, Crowe S, Stoove M, Hellard M, et al. Modelling the impact of migrants on the success of the HIV care and treatment program in Botswana. PLoS ONE. 2020;15: e0226422.
pubmed: 31940360
pmcid: 6961860
doi: 10.1371/journal.pone.0226422
Awad SF, Sgaier SK, Lau FK, Mohamoud YA, Tambatamba BC, Kripke KE, et al. Could circumcision of HIV-positive males benefit voluntary medical male circumcision programs in Africa? Mathematical Modeling Analysis. PLoS ONE. 2017;12: e0170641.
pubmed: 28118387
pmcid: 5261810
doi: 10.1371/journal.pone.0170641
Awad SF, Sgaier SK, Tambatamba BC, Mohamoud YA, Lau FK, Reed JB, et al. Investigating voluntary medical male circumcision program efficiency gains through subpopulation prioritization: insights from application to Zambia. PLoS ONE. 2015;10: e0145729.
pubmed: 26716442
pmcid: 4696770
doi: 10.1371/journal.pone.0145729
Awad SF, Sgaier SK, Ncube G, Xaba S, Mugurungi OM, Mhangara MM, et al. A reevaluation of the voluntary medical male circumcision scale-up plan in Zimbabwe. PLoS ONE. 2015;10: e0140818.
pubmed: 26529596
pmcid: 4646702
doi: 10.1371/journal.pone.0140818
Blaizot S, Huerga H, Riche B, Ellman T, Shroufi A, Etard J-F, et al. Combined interventions to reduce HIV incidence in KwaZulu-Natal: a modelling study. BMC Infect Dis. 2017;7:522.
doi: 10.1186/s12879-017-2612-5
Blaizot S, Maman D, Riche B, Mukui I, Kirubi B, Ecochard R, et al. Potential impact of multiple interventions on HIV incidence in a hyperendemic region in Western Kenya: a modelling study. BMC Infect Dis. 2016;16:189.
pubmed: 27129591
pmcid: 4851795
doi: 10.1186/s12879-016-1520-4
Blaizot S, Riche B, Maman D, Mukui I, Kirubi B, Etard J-F, et al. Estimation and short-term prediction of the course of the HIV epidemic using demographic and health survey methodology-like data. PLoS ONE. 2015;10: e0130387.
pubmed: 26091253
pmcid: 4474856
doi: 10.1371/journal.pone.0130387
MacFadden DR, Tan DH, Mishra S. Optimizing HIV pre-exposure prophylaxis implementation among men who have sex with men in a large urban centre: a dynamic modelling study. J Int AIDS Soc. 2016;19:20791.
pubmed: 27665722
pmcid: 5035769
doi: 10.7448/IAS.19.1.20791
Cremin I, Hallett TB. Estimating the range of potential epidemiological impact of pre-exposure prophylaxis: run-away success or run-away failure? AIDS 20155;29:733–8
Drabo EF, Hay JW, Vardavas R, Wagner ZR, Sood N. A cost-effectiveness analysis of preexposure prophylaxis for the prevention of HIV among Los Angeles county men who have sex with men. Clin Infect Dis United States. 2016;63:1495–504.
doi: 10.1093/cid/ciw578
Cremin I, Morales F, Jewell BL, O’Reilly KR, Hallett TB. Seasonal PrEP for partners of migrant miners in southern Mozambique: a highly focused PrEP intervention. J Int AIDS Soc. 2015;18:19946.
pubmed: 26198340
pmcid: 4509898
doi: 10.7448/IAS.18.4.19946
Gromov D, Bulla I, Silvia Serea O, Romero-Severson EO. Numerical optimal control for HIV prevention with dynamic budget allocation. Math Med Biol. 2018;35:469–91.
pubmed: 29106566
doi: 10.1093/imammb/dqx015
Smith JA, Garnett GP, Hallett TB. The Potential Impact of Long-Acting Cabotegravir for HIV Prevention in South Africa: A Mathematical Modeling Study. J Infect Dis [Internet]. United States; 2021;224:1179–86. Available from: http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=prem&NEWS=N&AN=32492704
Shen M, Xiao Y, Rong L, Meyers LA, Bellan SE. The cost-effectiveness of oral HIV pre-exposure prophylaxis and early antiretroviral therapy in the presence of drug resistance among men who have sex with men in San Francisco. BMC Med. 2018;16:58.
pubmed: 29688862
pmcid: 5914040
doi: 10.1186/s12916-018-1047-1
Adamson B, Garrison L, Barnabas RV, Carlson JJ, Kublin J, Dimitrov D. Competing biomedical HIV prevention strategies: potential cost-effectiveness of HIV vaccines and PrEP in Seattle, WA. J Int AIDS Soc. 2019;22: e25373.
pubmed: 31402591
pmcid: 6689690
doi: 10.1002/jia2.25373
Li J, Peng L, Gilmour S, Gu J, Ruan Y, Zou H, et al. A mathematical model of biomedical interventions for HIV prevention among men who have sex with men in China. BMC Infect Dis. 2018;18:600.
pubmed: 30486800
pmcid: 6263536
doi: 10.1186/s12879-018-3516-8
Foss AM, Vickerman PT, Heise L, Watts CH. Shifts in condom use following microbicide introduction: should we be concerned? AIDS [Internet]. 2003;17. Available from: https://journals.lww.com/aidsonline/Fulltext/2003/05230/Shifts_in_condom_use_following_microbicide.15.aspx
What Is the Impact of HIV on Racial and Ethnic Minorities in the U.S.? [Internet]. HIV.gov. [cited 2022 Jun 7]. Available from: https://www.hiv.gov/hiv-basics/overview/data-and-trends/impact-on-racial-and-ethnic-minorities
CDC. HIV and African American People [Internet]. 2022. Available from: https://www.cdc.gov/hiv/pdf/group/racialethnic/africanamericans/cdc-hiv-africanamericans.pdf
Huang Y-LA, Zhu W, Smith DK, Harris N, Hoover KW. HIV Preexposure Prophylaxis, by Race and Ethnicity - United States, 2014-2016. MMWR Morb Mortal Wkly Rep. 2018;67:1147–50.
Brantley ML, Rebeiro PF, Pettit AC, Sanders A, Cooper L, McGoy S, et al. Temporal trends and sociodemographic correlates of PrEP uptake in Tennessee, 2017. AIDS Behav. 2019;23:304–12.
pubmed: 31456198
pmcid: 6800596
doi: 10.1007/s10461-019-02657-8
Kanny D, Jeffries WL 4th, Chapin-Bardales J, Denning P, Cha S, Finlayson T, et al. Racial/ethnic disparities in HIV preexposure prophylaxis among men who have sex with men-23 Urban Areas, 2017. MMWR Morb Mortal Wkly Rep. 2019;68:801–6.
pubmed: 31536484
pmcid: 6755820
doi: 10.15585/mmwr.mm6837a2
Sidebottom D, Ekström AM, Strömdahl S, Sidebottom D, Ekstrom AM, Stromdahl S. A systematic review of adherence to oral pre exposure prophylaxis for HIV—how can we improve uptake and adherence? BMC Infect Dis. 2018;18(1):581.
pubmed: 30445925
pmcid: 6240194
doi: 10.1186/s12879-018-3463-4
Seekaew P, Pengnonyang S, Jantarapakde J, Meksena R, Sungsing T, Lujintanon S, et al. Discordance between self-perceived and actual risk of HIV infection among men who have sex with men and transgender women in Thailand: a cross-sectional assessment. J Int AIDS Soc. 2019;22: e25430.
pubmed: 31855324
pmcid: 6922021
doi: 10.1002/jia2.25430
Baidoobonso S, Bauer GR, Speechley KN, Lawson E. HIV risk perception and distribution of HIV risk among African, Caribbean and other Black people in a Canadian city: mixed methods results from the BLACCH study. BMC Public Health. 2013;13:184.
pubmed: 23452410
pmcid: 3599852
doi: 10.1186/1471-2458-13-184
Stringer EM, Sinkala M, Kumwenda R, Chapman V, Mwale A, Vermund SH, et al. Personal risk perception, HIV knowledge and risk avoidance behavior, and their relationships to actual HIV serostatus in an urban African obstetric population. J Acquir Immune Defic Syndr. 2004;35:60–6.
pubmed: 14707794
pmcid: 2745978
doi: 10.1097/00126334-200401010-00009
Kibombo R, Neema S, Ahmed FH. Perceptions of risk to HIV infection among adolescents in Uganda: are they related to sexual behaviour? Afr J Reprod Health. 2007;11:168–81.
pubmed: 18458740
pmcid: 2367132
doi: 10.2307/25549738
Maughan-Brown B, Venkataramani AS. Accuracy and determinants of perceived HIV risk among young women in South Africa. BMC Public Health. 2017;18:42.
pubmed: 28732496
pmcid: 5520344
doi: 10.1186/s12889-017-4593-0
Warren EA, Paterson P, Schulze WS, Lees S, Eaklel R, Stadler J, et al. Risk perception and the influence on uptake and use of biomedical prevention interventions for HIV in sub-Saharan Africa: a systematic literature review. PLoS ONE. 2018;13:6.
doi: 10.1371/journal.pone.0198680
Rozhnova G, Heijne J, Bezemer D, van Sighem A, Presanis A, De Angelis D, et al. Elimination prospects of the Dutch HIV epidemic among men who have sex with men in the era of preexposure prophylaxis. AIDS [Internet]. Lippincott Williams & Wilkins; 2018;32:2615–23. Available from: https://pubmed.ncbi.nlm.nih.gov/30379687
Barclay TR, Hinkin CH, Castellon SA, Mason KI, Reinhard MJ, Marion SD, et al. Age-associated predictors of medication adherence in HIV-positive adults: health beliefs, self-efficacy, and neurocognitive status. Health Psychol. 2007;26:40–9.
pubmed: 17209696
pmcid: 2863998
doi: 10.1037/0278-6133.26.1.40
Mallayasamy S, Chaturvedula A, Fossler MJ, Sale ME, Hendrix CW, Haberer JE. Assessment of demographic and socio-behavioral factors on adherence to HIV pre-exposure prophylaxis using a markov modeling approach. Front Pharmacol. 2019;10:785.
pubmed: 31354496
pmcid: 6639421
doi: 10.3389/fphar.2019.00785
Madrasi K, Chaturvedula A, Haberer JE, Sale M, Fossler MJ, Bangsberg D, et al. Markov mixed effects modeling using electronic adherence monitoring records identifies influential covariates to HIV preexposure prophylaxis. J Clin Pharmacol England. 2017;57:606–15.
doi: 10.1002/jcph.843
Spinelli MA, Glidden DV, Anderson PL, Gandhi M, Cohen S, Vittinghoff E, et al. Brief report: short-term adherence marker to PrEP predicts future nonretention in a large PrEP demo project: implications for point-of-care adherence testing. J Acquir Immune Defic Syndr. 2019;81:158–62.
pubmed: 31095005
pmcid: 6530484
doi: 10.1097/QAI.0000000000002005
Long EF, Stavert RR. Portfolios of biomedical HIV interventions in South Africa: a cost effectiveness analysis. J Gen Intern Med. 2013;28:1294–301.
pubmed: 23588668
pmcid: 3785647
doi: 10.1007/s11606-013-2417-1
Walensky RP. Combination HIV prevention: the value and interpretation of mathematical models. Curr HIV/AIDS Rep. 2013;10:195–8.
pubmed: 23797377
pmcid: 3784635
doi: 10.1007/s11904-013-0167-7
Wingood GM, Rubtsova A, DiClemente RJ, Metzger D, Blank M. A new paradigm for optimizing HIV intervention synergy: the role of interdependence in integrating HIV prevention interventions. J Acquir Immune Defic Syndr. 2013;63(Suppl 1):S108–13.
pubmed: 23673880
pmcid: 3660840
doi: 10.1097/QAI.0b013e318291fff4
Excler J-L, Rida W, Priddy F, Gilmour J, McDermott AB, Kamali A, et al. AIDS vaccines and preexposure prophylaxis: is synergy possible? AIDS Res Hum Retroviruses. 2011;27:669–80.
pubmed: 21043994
pmcid: 3101085
doi: 10.1089/aid.2010.0206
UNAIDS. FAST-TRACKING COMBINATION PREVENTION: TOWARDS REDUCING NEW HIV INFECTIONS TO FEWER THAN 500 000 BY 2020 [Internet]. 2015. Available from: https://www.unaids.org/sites/default/files/media_asset/20151019_JC2766_Fast-tracking_combination_prevention.pdf
Egger M, Johnson L, Althaus C, Schöni A, Salanti G, Low N, et al. Developing WHO guidelines: time to formally include evidence from mathematical modelling studies. F1000Research. 2017;6:1584.
pubmed: 29552335
doi: 10.12688/f1000research.12367.1
Turnovsky SJ. On the role of small models in macrodynamics. J Econ Dyn Control. 2011;35:1605–13.
doi: 10.1016/j.jedc.2011.05.003
Dorratoltaj N, Nikin-Beers R, Ciupe SM, Eubank SG, Abbas KM. Multi-scale immunoepidemiological modeling of within-host and between-host HIV dynamics: systematic review of mathematical models. PeerJ. 2017;5: e3877.
pubmed: 28970973
pmcid: 5623312
doi: 10.7717/peerj.3877
Akpa OM, Oyejola BA. Modeling the transmission dynamics of HIV/AIDS epidemics: an introduction and a review. J Infect Dev Ctries Italy. 2010;4:597–608.
doi: 10.3855/jidc.542
Birkegård AC, Halasa T, Toft N, Folkesson A, Græsbøll K. Send more data: a systematic review of mathematical models of antimicrobial resistance. Antimicrob Resist Infect Control. 2018;7:117. https://doi.org/10.1186/s13756-018-0406-1 .
doi: 10.1186/s13756-018-0406-1
pubmed: 30288257
pmcid: 6162961
Harris RC, Sumner T, Knight GM, White RG. Systematic review of mathematical models exploring the epidemiological impact of future TB vaccines. Hum Vaccin Immunother [Internet]. 2016/07/22. Taylor & Francis; 2016;12:2813–32. Available from: https://pubmed.ncbi.nlm.nih.gov/27448625
Grant H, Foss AM, Watts C, Medley GF, Mukandavire Z. Is modelling complexity always needed? Insights from modelling PrEP introduction in South Africa. J Public Health (Oxf). 2020;42:e551–60.
pubmed: 32026942
doi: 10.1093/pubmed/fdz178
Jenness SM, Sharma A, Goodreau SM, Rosenberg ES, Weiss KM, Hoover KW, et al. Individual HIV risk versus population impact of risk compensation after HIV preexposure prophylaxis initiation among men who have sex with men. PLoS ONE. 2017;12: e0169484.
pubmed: 28060881
pmcid: 5218403
doi: 10.1371/journal.pone.0169484
Jenness SM, Goodreau SM, Rosenberg E, Beylerian EN, Hoover KW, Smith DK, et al. Impact of the centers for disease control’s HIV preexposure prophylaxis guidelines for men who have sex with men in the United States. J Infect Dis. 2016;214:1800–7.
pubmed: 27418048
pmcid: 5142082
doi: 10.1093/infdis/jiw223
Goodreau SM, Rosenberg ES, Jenness SM, Luisi N, Stansfield SE, Millett GA, et al. Sources of racial disparities in HIV prevalence in men who have sex with men in Atlanta, GA, USA: a modelling study. Lancet HIV. 2017;4:e311–20.
pubmed: 28431923
pmcid: 5706457
doi: 10.1016/S2352-3018(17)30067-X
Müller B, Balbi S, Buchmann CM, de Sousa L, Dressler G, Groeneveld J, et al. Standardised and transparent model descriptions for agent-based models: Current status and prospects. Environ Model Softw [Internet]. 2014;55:156–63. Available from: https://www.sciencedirect.com/science/article/pii/S1364815214000395
Rueda ST, Terris-Prestholt F, et al. Health Economics Research on Non-Surgical, Biomedical HIV Prevention: Identifying Gaps and Proposing a Way Forward. Pharmacoeconomics. 2023;In Print.
Richardson BC. Richardson BC, Joscelyn KB, Saalberg JH, editors. Limitations on the use of mathematical models in transportation policy analysis1979. 1979.
Rojas-Vallejos J. Strengths and limitations of mathematical models in pandemicsthe case of COVID-19 in Chile. Medwave. 2020;20: e7876.
pubmed: 32343682
doi: 10.5867/medwave.2020.03.7874
Saltelli A, Bammer G, Bruno I, Charters E, Di Fiore M, Didier E, et al. Five ways to ensure that models serve society: a manifesto. Nature England. 2020;582:482–4.
doi: 10.1038/d41586-020-01812-9